Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer

Detalhes bibliográficos
Autor(a) principal: Albuquerque,George A. M. Lins de
Data de Publicação: 2017
Outros Autores: Guglielmetti,Giuliano B., Barbosa,João Arthur B. A., Pontes Jr.,José, Fazoli,Arnaldo J. C., Cordeiro,Maurício D., Coelho,Rafael F., Carvalho,Paulo Afonso de, Gallucci,Fábio P., Padovani,Guilherme P., Park,Rubens, Cury,José, Nonemacher,Henrique, Srougi,Miguel, Nahas,William C.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista da Associação Médica Brasileira (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302017000800704
Resumo: Summary Objective: To evaluate the relation between serum total testosterone (TT) and prostate cancer (PCa) grade and the effect of race and demographic characteristics on such association. Method: We analyzed 695 patients undergoing radical prostatectomy (RP), of whom 423 had serum TT collected. Patients were classified as having hypogonadism or eugonadism based on two thresholds of testosterone: threshold 1 (300 ng/dL) and threshold 2 (250 ng/dL). We evaluated the relation between TT levels and a Gleason score (GS) ≥ 7 in RP specimens. Outcomes were evaluated using univariate and multivariate analyses, accounting for race and other demographic predictors. Results: Out of 423 patients, 37.8% had hypogonadism based on the threshold 1 and 23.9% based on the threshold 2. Patients with hypogonadism, in both thresholds, had a higher chance of GS ≥ 7 (OR 1.79, p=0.02 and OR 2.08, p=0.012, respectively). In the multivariate analysis, adjusted for age, TT, body mass index (BMI) and race, low TT (p=0.023) and age (p=0.002) were found to be independent risk factors for GS ≥ 7. Among Black individuals, low serum TT was a stronger predictor of high-grade disease compared to White men (p=0.02). Conclusion: Hypogonadism is independently associated to higher GS in localized PCa. The effect of this association is significantly more pronounced among Black men and could partly explain aggressive characteristics of PCa found in this race.
id AMB-1_1af6c6311009d3d21ea12181d051899d
oai_identifier_str oai:scielo:S0104-42302017000800704
network_acronym_str AMB-1
network_name_str Revista da Associação Médica Brasileira (Online)
repository_id_str
spelling Low serum testosterone is a predictor of high-grade disease in patients with prostate cancerprostate cancerhypogonadismtestosteroneSummary Objective: To evaluate the relation between serum total testosterone (TT) and prostate cancer (PCa) grade and the effect of race and demographic characteristics on such association. Method: We analyzed 695 patients undergoing radical prostatectomy (RP), of whom 423 had serum TT collected. Patients were classified as having hypogonadism or eugonadism based on two thresholds of testosterone: threshold 1 (300 ng/dL) and threshold 2 (250 ng/dL). We evaluated the relation between TT levels and a Gleason score (GS) ≥ 7 in RP specimens. Outcomes were evaluated using univariate and multivariate analyses, accounting for race and other demographic predictors. Results: Out of 423 patients, 37.8% had hypogonadism based on the threshold 1 and 23.9% based on the threshold 2. Patients with hypogonadism, in both thresholds, had a higher chance of GS ≥ 7 (OR 1.79, p=0.02 and OR 2.08, p=0.012, respectively). In the multivariate analysis, adjusted for age, TT, body mass index (BMI) and race, low TT (p=0.023) and age (p=0.002) were found to be independent risk factors for GS ≥ 7. Among Black individuals, low serum TT was a stronger predictor of high-grade disease compared to White men (p=0.02). Conclusion: Hypogonadism is independently associated to higher GS in localized PCa. The effect of this association is significantly more pronounced among Black men and could partly explain aggressive characteristics of PCa found in this race.Associação Médica Brasileira2017-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302017000800704Revista da Associação Médica Brasileira v.63 n.8 2017reponame:Revista da Associação Médica Brasileira (Online)instname:Associação Médica Brasileira (AMB)instacron:AMB10.1590/1806-9282.63.08.704info:eu-repo/semantics/openAccessAlbuquerque,George A. M. Lins deGuglielmetti,Giuliano B.Barbosa,João Arthur B. A.Pontes Jr.,JoséFazoli,Arnaldo J. C.Cordeiro,Maurício D.Coelho,Rafael F.Carvalho,Paulo Afonso deGallucci,Fábio P.Padovani,Guilherme P.Park,RubensCury,JoséNonemacher,HenriqueSrougi,MiguelNahas,William C.eng2017-09-27T00:00:00Zoai:scielo:S0104-42302017000800704Revistahttps://ramb.amb.org.br/ultimas-edicoes/#https://old.scielo.br/oai/scielo-oai.php||ramb@amb.org.br1806-92820104-4230opendoar:2017-09-27T00:00Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)false
dc.title.none.fl_str_mv Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer
title Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer
spellingShingle Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer
Albuquerque,George A. M. Lins de
prostate cancer
hypogonadism
testosterone
title_short Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer
title_full Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer
title_fullStr Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer
title_full_unstemmed Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer
title_sort Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer
author Albuquerque,George A. M. Lins de
author_facet Albuquerque,George A. M. Lins de
Guglielmetti,Giuliano B.
Barbosa,João Arthur B. A.
Pontes Jr.,José
Fazoli,Arnaldo J. C.
Cordeiro,Maurício D.
Coelho,Rafael F.
Carvalho,Paulo Afonso de
Gallucci,Fábio P.
Padovani,Guilherme P.
Park,Rubens
Cury,José
Nonemacher,Henrique
Srougi,Miguel
Nahas,William C.
author_role author
author2 Guglielmetti,Giuliano B.
Barbosa,João Arthur B. A.
Pontes Jr.,José
Fazoli,Arnaldo J. C.
Cordeiro,Maurício D.
Coelho,Rafael F.
Carvalho,Paulo Afonso de
Gallucci,Fábio P.
Padovani,Guilherme P.
Park,Rubens
Cury,José
Nonemacher,Henrique
Srougi,Miguel
Nahas,William C.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Albuquerque,George A. M. Lins de
Guglielmetti,Giuliano B.
Barbosa,João Arthur B. A.
Pontes Jr.,José
Fazoli,Arnaldo J. C.
Cordeiro,Maurício D.
Coelho,Rafael F.
Carvalho,Paulo Afonso de
Gallucci,Fábio P.
Padovani,Guilherme P.
Park,Rubens
Cury,José
Nonemacher,Henrique
Srougi,Miguel
Nahas,William C.
dc.subject.por.fl_str_mv prostate cancer
hypogonadism
testosterone
topic prostate cancer
hypogonadism
testosterone
description Summary Objective: To evaluate the relation between serum total testosterone (TT) and prostate cancer (PCa) grade and the effect of race and demographic characteristics on such association. Method: We analyzed 695 patients undergoing radical prostatectomy (RP), of whom 423 had serum TT collected. Patients were classified as having hypogonadism or eugonadism based on two thresholds of testosterone: threshold 1 (300 ng/dL) and threshold 2 (250 ng/dL). We evaluated the relation between TT levels and a Gleason score (GS) ≥ 7 in RP specimens. Outcomes were evaluated using univariate and multivariate analyses, accounting for race and other demographic predictors. Results: Out of 423 patients, 37.8% had hypogonadism based on the threshold 1 and 23.9% based on the threshold 2. Patients with hypogonadism, in both thresholds, had a higher chance of GS ≥ 7 (OR 1.79, p=0.02 and OR 2.08, p=0.012, respectively). In the multivariate analysis, adjusted for age, TT, body mass index (BMI) and race, low TT (p=0.023) and age (p=0.002) were found to be independent risk factors for GS ≥ 7. Among Black individuals, low serum TT was a stronger predictor of high-grade disease compared to White men (p=0.02). Conclusion: Hypogonadism is independently associated to higher GS in localized PCa. The effect of this association is significantly more pronounced among Black men and could partly explain aggressive characteristics of PCa found in this race.
publishDate 2017
dc.date.none.fl_str_mv 2017-08-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302017000800704
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302017000800704
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1806-9282.63.08.704
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Médica Brasileira
publisher.none.fl_str_mv Associação Médica Brasileira
dc.source.none.fl_str_mv Revista da Associação Médica Brasileira v.63 n.8 2017
reponame:Revista da Associação Médica Brasileira (Online)
instname:Associação Médica Brasileira (AMB)
instacron:AMB
instname_str Associação Médica Brasileira (AMB)
instacron_str AMB
institution AMB
reponame_str Revista da Associação Médica Brasileira (Online)
collection Revista da Associação Médica Brasileira (Online)
repository.name.fl_str_mv Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)
repository.mail.fl_str_mv ||ramb@amb.org.br
_version_ 1754212832936722432